ZoomMed Enters Into an Exclusive Agreement to Market and Implement the Medical Interactive Communication Platform "CESAMSPHERE"
22 Novembro 2011 - 12:18PM
Marketwired
ZoomMed Inc. (TSX: ZMD), is pleased to announce it has entered into
an exclusive agreement to market and implement "CESAMSPHERE" a
secured medical interactive communication platform developed by
"Centre d'Expertises et de Services pour l'Avancement Medical Inc.
(CESAM)".
The concluded agreement with CESAM will provide the addition of
new functionalities to the ZRx Prescriber, such as medical
tele-expertise, continuing medical education and laboratory
diagnostic tests analysis by specialists, strengthening the bridge
between physicians, pharmacists and the other stakeholders in the
healthcare community.
"I am convinced that including this platform to our product
offering will significantly contribute to facilitate the healthcare
professional's tasks, now allowing, via the ZRx Prescriber,
interactive communication between specialists, general
practitioners, and pharmacists" says M. Yves Marmet, President and
CEO of ZoomMed.
"Furthermore, this Web-platform, which was developed,
particularly, to operate on wireless devices and smart phones
identical to ZoomMed's, includes many applications which raise
strong interest not only from the healthcare community and
particularly pharmaceutical corporations, but to major
telecommunication corporations", concluded M. Marmet.
About CESAMSPHERE
The tele-expertise application allows to, via the ZRx
Prescriber, receive medical advices, offer support services related
to prescription drugs, avoid unnecessary hospitalizations, enhance
patient's therapeutic treatment, and promote delivery of community
care.
Continued medical education is an application which allows, via
the ZRx Prescriber, healthcare industry's educational program
development by putting in place mentoring program throughout Canada
and the United States.
Moreover, laboratory diagnostic tests analysis by specialists
provide physicians and pharmacists with the ability to send
personalized preventive medical consultation requests.
For further information on CESAMSPHERE, visit the following Web
Site: www.cesamsphere.com
About ZoomMed
ZoomMed developed the ZRx Prescriber, a technological innovative
Web application that enables physicians to use a wireless device,
such as the IPod Touch(TM), IPhone(TM), IPad(TM), Google
Android(TM), other PDA's or computers, to write and rapidly deliver
scripts. The ZRx Prescriber is quick, efficient and intuitive.
Since it is a stand-alone product, it can easily be integrated to
any Electronic Medical Record application (EMR). Furthermore,
ZoomMed also offers "PraxisLab" a new application that enhances all
aspects of the prescription filling process and the complete
pharmacists patient file management. PraxisLab uses
state-of-the-art protocols and up-to-date software standards,
allowing high compatibility with existing software, as well as new
generation software.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Contacts: ZoomMed Mr. Yves Marmet President and Chief Executive
Officer (450) 678-5457, ext 228info@zoommed.comwww.zoommed.com
Zoommed (TSXV:ZMD)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Zoommed (TSXV:ZMD)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024